We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





New Low-cost COVID-19 Test Detects Coronavirus in 20 Minutes

By LabMedica International staff writers
Posted on 18 Aug 2020
Print article
Illustration
Illustration
Scientists at the University of Melbourne (Melbourne, Australia) have developed a low-cost nasal swab test which can diagnose the presence of SARS-CoV-2 virus in 20 minutes.

The test named N1-STOP-LAMP is 100% accurate in diagnosing samples containing SARS-CoV-2 at high loads and could help in fast-tracking COVID testing. The method involves using a small portable machine, which can reliably detect SARS-CoV-2 from just one nasal swab. The test uses just one tube and involves only a single step, making it more efficient and lower cost than several SARS-CoV-2 tests that are currently available. In an assessment of 157 confirmed-positive samples by the researchers, the N1-STOP-LAMP method correctly identified 87% of tests as positive with an average time-to-positive of 14 minutes for 93 of those clinical samples.

According to the researchers, STOP-LAMP is referred to as a ‘near care’ test and is not intended to replace the current gold standard PCR testing. Despite being a robust diagnostic test for the specific and rapid detection of COVID-19, the N1-STOP-LAMP trades some detection sensitivity for speed and ease-of-use.

“In the race to control the COVID-19 pandemic, access to rapid, precision diagnostics is key,” said Tim Stinear, a professor at the University of Melbourne in Australia. “We have developed an alternative COVID-19 molecular test that can be readily deployed in settings where access to standard laboratory testing is limited or where ultra-rapid result turnaround times are needed.”

Related Links:

University of Melbourne

Gold Member
COVID-19 TEST READER
COVID-19-CHECK-1 EASY READER+
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory QC Panel
Assayed Respiratory Control Panel
New
H.pylori Test
Humasis H.pylori Card

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.